Renal disease and the heart

Revision as of 15:38, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Myocardial infarction
Diagram of a myocardial infarction (2) of the tip of the anterior wall of the heart (an apical infarct) after occlusion (1) of a branch of the left coronary artery (LCA, right coronary artery = RCA).
ICD-10 I21-I22
ICD-9 410
DiseasesDB 8664
MedlinePlus 000195
eMedicine med/1567  emerg/327 ped/2520

WikiDoc Resources for Renal disease and the heart

Articles

Most recent articles on Renal disease and the heart

Most cited articles on Renal disease and the heart

Review articles on Renal disease and the heart

Articles on Renal disease and the heart in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Renal disease and the heart

Images of Renal disease and the heart

Photos of Renal disease and the heart

Podcasts & MP3s on Renal disease and the heart

Videos on Renal disease and the heart

Evidence Based Medicine

Cochrane Collaboration on Renal disease and the heart

Bandolier on Renal disease and the heart

TRIP on Renal disease and the heart

Clinical Trials

Ongoing Trials on Renal disease and the heart at Clinical Trials.gov

Trial results on Renal disease and the heart

Clinical Trials on Renal disease and the heart at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Renal disease and the heart

NICE Guidance on Renal disease and the heart

NHS PRODIGY Guidance

FDA on Renal disease and the heart

CDC on Renal disease and the heart

Books

Books on Renal disease and the heart

News

Renal disease and the heart in the news

Be alerted to news on Renal disease and the heart

News trends on Renal disease and the heart

Commentary

Blogs on Renal disease and the heart

Definitions

Definitions of Renal disease and the heart

Patient Resources / Community

Patient resources on Renal disease and the heart

Discussion groups on Renal disease and the heart

Patient Handouts on Renal disease and the heart

Directions to Hospitals Treating Renal disease and the heart

Risk calculators and risk factors for Renal disease and the heart

Healthcare Provider Resources

Symptoms of Renal disease and the heart

Causes & Risk Factors for Renal disease and the heart

Diagnostic studies for Renal disease and the heart

Treatment of Renal disease and the heart

Continuing Medical Education (CME)

CME Programs on Renal disease and the heart

International

Renal disease and the heart en Espanol

Renal disease and the heart en Francais

Business

Renal disease and the heart in the Marketplace

Patents on Renal disease and the heart

Experimental / Informatics

List of terms related to Renal disease and the heart

Cardiology Network

Discuss Renal disease and the heart further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]


Overview

An estimated 10 to 20 million people have chronic kidney disease (CKD). While many will never develop kidney failure, others will, joining more than 400,000 people annually treated with dialysis or a kidney transplant. Cardiovascular disorders accounts for half of all deaths among people with kidney failure.

  • Cardiovascular disease accounts for more than half of all deaths among people with renal failure.
  • Even early or mild kidney disease places a person at higher risk of acute coronary syndromes and heart failure, as well as cardiovascular disease related death.
  • Hypertension (high blood pressure) and diabetes are major risk factors for chronic kidney disease and heart disease. The development of chronic kidney disease in persons with diabetes or hypertension further increases the risk of developing cardiovascular disease.
  • Hypertension increases the risk of cardiovascular disease, and severe hypertension can cause extensive and rapidly progressive kidney damage. Newer medications that better control blood pressure, however, can slow the rate of kidney damage only by about 50 percent.
  • In comparison, death from cardiovascular disease is 10 to 30 times more likely in dialysis patients.
  • Kidney disease by itself increases the risk of cardiovascular disease, even with concurrent diabetes, hypertension and high cholesterol.
  • Numerous studies reported that kidney disease accelerates heart disease, even before the kidneys are damaged to the point of needing dialysis or transplantation.

Clinical Trials

A pair of epidemiology studies confirmed that chronic kidney disease independently increases the risk of developing cardiovascular disease, even among people with early kidney disease and after considering other risk factors such as diabetes, hypertension and high cholesterol.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded study followed more than 1.1 million adults from the Kaiser Permanente Renal Registry in San Francisco for nearly 3 years; average age was 52 years. The investigators found that when kidney function (GFR) dropped, the risk of death, cardiovascular events such as heart disease and stroke, and hospitalization increased. Compared to patients whose GFR was at least 60 (ml per min. per 1.73 m2):

  • The increased risk of death ranged from 17 percent in those whose GFR was between 45 and 59 to about 600 percent in those whose GFR was less than 15
  • The increased risk of CVD events ranged from 43 percent in those whose GFR was between 45 and 59 to 343 percent in those whose GFR was less than 15,
  • The increased risk of hospitalization ranged from 14 percent in those whose GFR was between 45 and 59 to 315 percent in those whose GFR was less than 15.

The industry-funded VALIANT study related CKD to deaths from CVD in a 2-year drug-treatment trial of more than 14,500 heart-attack patients. The researchers found death rates ranging from 14.1 percent in patients whose GFR was at least 75 to 45.5 percent in those whose GFR was less than 45.

The investigators attribute the increased risk of death from CVD in part to complications of kidney disease, including anemia, oxidative stress, changes in calcium and phosphate regulation, inflammation, and conditions promoting clotting. The researchers also suggest that other kidney-related factors such as protein in the urine and elevated blood levels of both homocysteine and uric acid may increase the risk of CVD and death. Furthermore, they found that common CVD therapies such as aspirin and beta-blockers were “curiously underused” in CKD patients with lower kidney function, perhaps inspired by a fatalist mind-set that may be a self-fulfilling prophecy.

Renal Cell Carcinoma and Heart

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Source

  • National Institute of Health


Template:WikiDoc Sources